Innovation Projects

Genomic testing and predictive disease modelling to guide therapy and reduce the burden of prostate cancer diagnosis.

Next-generation sequencing to find new solutions for patients with common endometrial-related health problems.

Establishing a comprehensive patient dataset of inherited retinal diseases, providing information to drive new treatments and therapies for the most common cause of blindness.

Developing a rapid multi-omic liquid biopsy blood test utilising whole genome sequencing to resolve the difficult diagnosis of cancer of unknown primary origin.

The University of Melbourne Centre for Cancer Research’s clinical genomics team received support from the TAGC Innovation Fund to pioneer a less invasive way to collect tumour information from a simple blood test by deciphering small amounts of cancer-specific mutations in the bloodstream known as circulating tumour DNA (or ctDNA).

Researchers at the Doherty Institute, in collaboration with computational biologists at the Melbourne School of Engineering and the Walter & Eliza Hall Institute received a $2 million grant to better understand disease progression in patients with COVID-19.